St George's, University of London
sgul.ac.ukTotal trials
106
Active
8
Phase 3
9
Total enrollment
58,854
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Stroke7
- Hypertension6
- Group B Strep Infection4
- HIV Infections4
- Pregnancy Related4
- Pertussis4
- Group B Streptococcus Carrier in Childbirth3
- Group B Streptococcal Infection, Late-Onset3
Frequently asked questions about St George's, University of London
- How many clinical trials does St George's, University of London have on ClinicalTrials.gov?
- St George's, University of London is listed as the lead sponsor on 106 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of St George's, University of London's trials are in Phase 3?
- 9 of St George's, University of London's trials are in Phase 3.
- What therapeutic areas does St George's, University of London focus on?
- St George's, University of London's most-studied conditions on ClinicalTrials.gov are Stroke, Hypertension, Group B Strep Infection, HIV Infections, Pregnancy Related.